Sr. No | Name of PI | Host Institute Name | Sponsored Institute Name | Subject |
| Wadhwani AI Pvt. Ltd | AI Powered Clinical Decision Support System (CDSS) for Patient Triaging and to Assist Doctors and Patients in Improving Quality Patients Consultation. | |||
| 1. | Dr. Prasan Kumar Panda | AIIMS,Rishikesh | PGIMER Chandigarh | A multicentric point prevalence survey of antimicrobial prescription, AMR, and HAI in tertiary care hospitals of India |
| ICMR | WHO implementation in india for the international randomized trial of additional treatments for COVID-19 in Hospitalized patients who are receiving the local standard of care | |||
| ICMR | Randomised Evaluation of COVID-19 Therapy (RECOVERY) | |||
| 2. | Dr. Uttam Kumar Nath | AIIMS, Rishikesh | Medpace Clinical Research, LLC | 1) Phase 3 study of evaluate Phase 3 study of evaluate the efficacy and safety of subcutaneous Marzeptacog Alfa activated for on demand treatment control of bleeding episodes in subjects with haemophilia A or Haemophilia B, with inhibitors: the crimson 1 Study 2) JSS Medical Research India Pvt Ltd – PTG-300-04 Phase 2 study of the Hepeidin Mimetic PTG-300 in patients with phlebotomy-Requiring polycythemia vera 3) CSIR-CDRI – Delineate molecular mechanism in development of chemo- resistance in non-Hodgkin’s lymphoma 4) CSIR – Identification of Molecular therapeutic target leading to development of chemo’resistance in non-GC DLBCL patients in India |
| 3. | Prof. Manoj Gupta | AIIMS, Rishikesh | Tata Memorial Centre | Vastectomy ladiation fherapy in High Rislq llgde lQgative women with Early lreast Qancer |
| 4. | Prof. Vartika Saxena | AIIMS, Rishikesh | ICMR-NIE | 1) Effectiveness of covaxin and covishield vaccines against severe COVID-19 in India, 2021: multi-centric hospital based, case control study 2) Central council for Research in Yoga & Naturopathy (CCRYN) New Delhi – To set up a center of Mind Body Medicine for Research, Training, and patient care 3) University of South Wales, United Kingdom – Strengthening health systems to support family resilience in post pandemic India. Discussion may extend to consider, opportunities for further complimentary collaborations |
| 5. | Dr. Vijay Krishnan | AIIMS, Rishikesh | National Institute of Mental Health and Neuro Sciences | The role of obstructive sleep apnoea in the evaluation of metabolic syndrome in patients of treatment with second generation antipsychotics |
| 6. | Dr. Amit Sehrawat | AIIMS, Rishikesh | Astrazeneca Pharma India Ltd | 1) A Phase 3, Open-label, Randomized Study of Dato-DXd Versus Investigator’sChoice of Chemotherapy in Participants With Inoperable or Metastatic Hormone ReceptorPositive, HER2 Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION Breast0l) 2) Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) – Neoadjuvant chemotherapy followed by Surgery versus surgery followed by adjuvant chemotherapy for resectable Gastric Adenocarcinoma-Phase 3 Multicentric Randomized controlled trial (NAGA study) |
| 7. | Prof. Bhanu Duggal | AIIMS, Rishikesh | Biotechnology industry Research Assistant Council, | 1) Smartphone based rapid, portable cardiac biosensor device using flexible gel-less antibacterial array 2) Indian Institute of Technology, Jodhpur Rajasthan – Collaborative Training, Education and Research 3) IIT Jodhpur – Collaborative Education and Research |
| 8. | Prof. Latika Mohan | AIIMS, Rishikesh | Indian Institute of Science Bangalore | 1) Designing and automated algorithm to detect seizures using previously recorded electroencephalograms of diagnosed epilepsy patents in a tertiary care centre |
| 9. | Dr. Niraj Kumar | AIIMS, Rishikesh | IIT Roorkee | 1) Developing a low-cost smart assistive device for voice rehabilitation of patients affected with Parkinson’s disease and assess its efficacy and acceptability (SMART VOICE PD) |
| 10. | Dr. Yogesh Bahurupi | AIIMS, Rishikesh | ICMR | 1) An open-label, multicentre, randomised, adaptive platform trial of the safety and efficacy of several therapies, including antiviral therapies, versus control in mild cases of COVID-19 |
| 11. | Dr. Anupam | AIIMS, Rishikesh | Government Doon Medical College (DGMC) | 1) Analysing barriers for the visual health among strabismus patients: A parental survey |
| 12. | Prof. Shalini Rajaram | AIIMS, Rishikesh | ICMR | 1) Evaluation of indocyanine (ICG) and Handheld fluorescence imager in the management of early stage gynaecological cancer |
| 13. | Dr. Yogesh Bahurupi | AIIMS, Rishikesh | John Snow India Pvt Ltd. (JSI) | 1) Sentinel surveillance for adverse events of special interest (AESI) following COVID-19 vaccination in india |